KBC Group
MRK icon

KBC Group’s Merck MRK Stock Holding History

KBC Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146M Sell
1,217,611
-60,520
-5% -$6.99M 0.37% 51
2025
Q4 		$135M Buy
1,278,131
+107,602
+9% +$10.1M 0.31% 67
2025
Q3 		$98.2M Sell
1,170,529
-1,309,338
-53% -$108M 0.24% 92
2025
Q2 		$196M Buy
2,479,867
+90,834
+4% +$7.22M 0.53% 31
2025
Q1 		$214M Sell
2,389,033
-227,229
-9% -$21.2M 0.67% 24
2024
Q4 		$260M Buy
2,616,262
+134,403
+5% +$13.9M 0.72% 19
2024
Q3 		$282M Sell
2,481,859
-884,248
-26% -$105M 0.85% 16
2024
Q2 		$417M Buy
3,366,107
+978,655
+41% +$126M 1.26% 11
2024
Q1 		$315M Sell
2,387,452
-8,675
-0.4% -$1.07M 1% 14
2023
Q4 		$261M Buy
2,396,127
+196,508
+9% +$20.4M 0.93% 16
2023
Q3 		$226M Buy
2,199,619
+412,320
+23% +$44.4M 0.92% 16
2023
Q2 		$206M Sell
1,787,299
-84,015
-4% -$9.54M 0.85% 18
2023
Q1 		$199M Sell
1,871,314
-520,820
-22% -$56.2M 0.85% 20
2022
Q4 		$265M Buy
2,392,134
+439,625
+23% +$44.9M 1.29% 10
2022
Q3 		$168M Sell
1,952,509
-35,735
-2% -$3.19M 0.87% 19
2022
Q2 		$181M Buy
1,988,244
+1,230,521
+162% +$109M 0.9% 19
2022
Q1 		$62.2M Sell
757,723
-883,835
-54% -$69.7M 0.25% 107
2021
Q4 		$126M Buy
1,641,558
+262,944
+19% +$20.9M 0.42% 58
2021
Q3 		$104M Sell
1,378,614
-3,910,830
-74% -$297M 0.38% 64
2021
Q2 		$411M Buy
5,289,444
+110,119
+2% +$8.19M 0.74% 22
2021
Q1 		$381M Sell
5,179,325
-530,122
-9% -$39.1M 0.77% 19
2020
Q4 		$2.34B Buy
5,709,447
+754,654
+15% +$57.7M 1% 13
2020
Q3 		$392M Sell
4,954,793
-201,352
-4% -$15.8M 1.16% 11
2020
Q2 		$380M Buy
5,156,145
+2,522,143
+96% +$190M 1.27% 10
2020
Q1 		$193M Buy
2,634,002
+157,291
+6% +$12.4M 1.62% 5
2019
Q4 		$215M Buy
2,476,711
+17,975
+0.7% +$1.48M 1.36% 5
2019
Q3 		$197M Buy
2,458,736
+247,538
+11% +$19.8M 1.45% 5
2019
Q2 		$177M Buy
2,211,198
+343,640
+18% +$26.3M 1.37% 5
2019
Q1 		$148M Buy
1,867,558
+841,066
+82% +$62.9M 1.22% 7
2018
Q4 		$74.8M Sell
1,026,492
-215,092
-17% -$15.2M 0.83% 14
2018
Q3 		$84M Buy
1,241,584
+8,015
+0.6% +$511K 0.64% 19
2018
Q2 		$71.4M Sell
1,233,569
-99,923
-7% -$5.64M 0.62% 23
2018
Q1 		$69.3M Sell
1,333,492
-450,651
-25% -$24.3M 0.64% 25
2017
Q4 		$95.8M Sell
1,784,143
-293,586
-14% -$16.3M 0.82% 17
2017
Q3 		$127M Buy
2,077,729
+46,111
+2% +$2.8M 1.15% 10
2017
Q2 		$124M Sell
2,031,618
-124,406
-6% -$7.57M 1.2% 9
2017
Q1 		$131M Buy
2,156,024
+371,817
+21% +$22.6M 1.18% 9
2016
Q4 		$100M Buy
1,784,207
+318,933
+22% +$18.7M 0.99% 11
2016
Q3 		$87.3M Buy
1,465,274
+361,133
+33% +$21.1M 1.03% 10
2016
Q2 		$60.7M Buy
1,104,141
+470,236
+74% +$25M 0.87% 13
2016
Q1 		$32M Buy
633,905
+74,632
+13% +$3.66M 0.53% 33
2015
Q4 		$28.2M Sell
559,273
-67,873
-11% -$3.42M 0.52% 38
2015
Q3 		$29.6M Sell
627,146
-269,493
-30% -$14.3M 0.59% 24
2015
Q2 		$48.7M Buy
896,639
+22,720
+3% +$1.27M 0.63% 19
2015
Q1 		$47.9M Sell
873,919
-204,716
-19% -$11.6M 0.61% 28
2014
Q4 		$58.5M Buy
1,078,635
+845,324
+362% +$47.1M 0.7% 21
2014
Q3 		$13.2M Sell
233,311
-867,212
-79% -$48.7M 0.46% 31
2014
Q2 		$60.7M Sell
1,100,523
-17,261
-2% -$942K 0.69% 22
2014
Q1 		$60.5M Sell
1,117,784
-69,919
-6% -$3.62M 0.96% 12
2013
Q4 		$56.7M Buy
1,187,703
+136,341
+13% +$6.23M 0.86% 12
2013
Q3 		$47.8M Buy
1,051,362
+72,331
+7% +$3.3M 0.77% 14
2013
Q2 		$43.4M Buy
+979,031
New +$43.7M 0.81% 15

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KBC Group's MRK Position: Q1 2026 in Review

KBC Group reduced its Merck (MRK) stake by 4.7% in Q1 2026, selling an estimated $6.99M and leaving 1,217,611 shares worth $146M. The position accounts for 0.37% of the portfolio, ranked #51.

KBC Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.34B in Q4 2020. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • KBC Group held 1,217,611 shares of Merck worth $146M as of Q1 2026.
  • KBC Group sold 60,520 Merck shares in Q1 2026, an estimated $6.99M.
  • Merck made up 0.37% of KBC Group's portfolio in Q1 2026, its #51 holding.
  • KBC Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Merck position peaked at $2.34B in Q4 2020.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.